TRDA Entrada Therapeutics, Inc.
Healthcare$6.39+0.00%OpenMarket Cap: $248.1M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
2
Dispositions
4
Buy/Sell Ratio
0.50
Net Shares
-38,407
Shares Acquired
20,000
Shares Disposed
58,407
Total Bought ($)
$1.00
Total Sold ($)
$3.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu May 21 | Zeiher Bernhardt G | director | Buy | 5,000 | $5.86 | 5,000 |
| Mon May 04 | Sethuraman Natarajan | officer: President, Research & Develop. | Sell | 25,907 | $15.39 | 216,317 |
| Mon May 04 | Dowden Nathan J | officer: President & COO | Sell | 15,000 | $15.33 | 198,588 |
| Mon May 04 | Dowden Nathan J | officer: President & COO | Sell | 15,000 | $1.74 | 213,588 |
| Thu Apr 02 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | Sell | 2,500 | $12.95 | 119,010 |
| Wed Mar 11 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | Sell | 11,388 | $13.02 | 121,510 |
| Wed Mar 11 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | Sell | 5,089 | $13.00 | 132,898 |
| Wed Mar 11 | Dowden Nathan J | officer: President & COO | Sell | 11,894 | $13.05 | 198,588 |
| Wed Mar 11 | Dowden Nathan J | officer: President & COO | Sell | 3,116 | $13.02 | 210,482 |
| Fri Mar 06 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | Sell | 7,988 | $12.25 | 137,987 |
| Tue Mar 03 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | Sell | 44,600 | $0.00 | 154,626 |
| Tue Mar 03 | Doshi Dipal | director, officer: CEO | Sell | 19,181 | $11.76 | 526,014 |
| Tue Mar 03 | Doshi Dipal | director, officer: CEO | Sell | 9,869 | $11.66 | 545,195 |
| Tue Mar 03 | Doshi Dipal | director, officer: CEO | Sell | 208,000 | $11.93 | 208,000 |
| Tue Mar 03 | Doshi Dipal | director, officer: CEO | Sell | 139,400 | $0.00 | 555,064 |